[company_age]15.0[/company_age][employees]11-50 employees[/employees][funding]Series C[/funding][description]Humedics GmbH, a Berlin-based medical technology company, revolutionizes liver function assessment with its innovative LiMAx® technology. This non-invasive breath test analyzes exhaled air to provide physicians with a quantitative measure of an individual's liver function capacity within minutes. This real-time information empowers physicians to make informed decisions about treatment strategies and monitor disease progression based on the functional health of the liver.\n\nHumedics distinguishes itself from competitors by focusing on a painless, convenient, and rapid breath-based approach. Unlike traditional methods relying on blood tests or imaging, LiMAx® offers a unique and valuable tool for personalized medicine and improved patient outcomes. The company's commitment to research and development ensures continuous innovation and expansion of its technology's capabilities, as evidenced by over 20 ongoing studies exploring new applications for LiMAx®.\n\nHumedics' target market is B2B, specifically physicians in the fields of liver surgery and transplantation, hepatology, and oncology. The LiMAx® test is currently in routine clinical use at over 30 leading university hospitals in Europe and has been commercially available in Germany, Austria, and the UK. With over 20,000 tests performed to date, Humedics is poised to make a significant impact on the field of liver diagnostics.[/description][ps]LiMAx® - Non-invasive breath test for liver function assessment.[/ps]